Antidiabetic Properties and Toxicological Assessment of Antidesma celebicum Miq: Ethanolic Leaves Extract in Sprague–Dawley Rats

Table 4

Lipid profiles of experimental animals after 28 days oral administration of EEAC from antidiabetic activity study.

Groups	Lipid profiles (mg/dl)
	CHOL	HDL	LDL	TG
NC	61.60 ± 3.14^bd	35.30 ± 1.29	37.20 ± 0.80^b	93.30 ± 4.14^b
DC	144.60 ± 19.47^ac	43.94 ± 3.55	61.40 ± 5.35^a	269.40 ± 69.29^a
DC + 200 mg/kg EEAC	138.00 ± 14.71^a	43.10 ± 5.13	60.40 ± 3.14^a	253.80 ± 15.57^a
DC + 400 mg/kg EEAC	79.20 ± 7.91^bd	39.70 ± 4.50	45.00 ± 5.22	182.40 ± 25.63
DC + acarbose	87.00 ± 8.60^b	39.76 ± 3.65	47.20 ± 3.65	130.20 ± 12.46

NC: normal control, DC: diabetic control, CHOL: cholesterol, HDL: high-density lipoprotein, LDL: low-density lipoprotein, TG: triglyceride. Results are expressed as mean ± SEM (n = 5). (^a) means significantly different from NC group; (^b) means significantly different from DC group; (^c) means significantly different from DC + acarbose group; (^d) means significantly different from DC + 200 mg/kg EEAC group ().